Last updated on December 2018

Safety and Efficacy Study of PG324 (Netarsudil/Latanoprost 0.02% / 0.005%) Ophthalmic Solution Compared to GANFORT Ophthalmic Solution in Open Angle Glaucoma or Ocular Hypertension


Brief description of study

The study is intended to test the effectiveness and safety of Netarsudil / Latanoprost 0.02% / 0.005% Ophthalmic Solution, relative to GANFORT for lowering of intraocular pressure (IOP) in patients with elevated intraocular pressure

Clinical Study Identifier: NCT03284853

Contact Investigators or Research Sites near you

Start Over

Mark Herring

University Medical Center Freiburg
Freiburg im Breisgau, Germany
  Connect »